Scott L. Friedman

5 ta ish

Icahn School of Medicine at Mount Sinai

1. Mechanisms of NAFLD development and therapeutic strategies

   Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella +1

   Sharh maqola20184 iqtibos

   ABIABI:AkademIndex/2026.other.519394

2. Mechanisms of hepatic stellate cell activation

   Takuma Tsuchida, Scott L. Friedman

   Sharh maqola20173 iqtibos

   ABIABI:AkademIndex/2026.other.293367

3. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis

   Daniela Sia, Augusto Villanueva, Scott L. Friedman +1

   Sharh maqolaOAOchiq kirish20162 iqtibos

   ABIABI:AkademIndex/2026.other.149011

4. Liver fibrosis – from bench to bedside

   Scott L. Friedman

   Sharh maqola20032 iqtibos

   ABIABI:AkademIndex/2026.other.516600

5. E3 Ubiquitin Ligase Synoviolin Is Involved in Liver Fibrogenesis

   Daisuke Hasegawa, Ryoji Fujii, Naoko Yagishita +18

   Maqola20102 iqtibos

   ABIABI:AkademIndex/2026.other.623626